Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2975 Next Generation Sequencing of Pancreatic Neuroendocrine Tumors in Russian Cohort
Introduction: The appearance of next generation sequencing (NGS), - a powerful high-performance method, allowed accumulation of a large amount of information concerning genetic and epigenetic patterns, however, the problem of matching clinical, histological picture with genetic structure in pNETs remains open.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Trifanov V
Authors: Trifanov V, Kit O, Timoshkina N, Gvaldin D, Karnauhov N,
Keywords: Next generation sequencing, pancreatic neuroendocrine tumors,
Introduction: In PanNEN cases, treatment strategies are decided by tumor localization, volume and grade. In unresectable or metastatic cases, tumor grade is determined by biopsy specimen obtained from EUS-FNA and diagnostic accuracy of biopsy according to WHO classification 2017 is important for decision making of treatment.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Nakano K, Masui T, Yogo A, Uchida Y, Nagai K,
Keywords: PanNEN, WHO classification 2017, EUS-FNA, Ki-67, biopsy, surgical pathology, discordance,
Introduction:
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Nakano K, Masui T, Yogo A, Uchida Y, Sato A,
Keywords: everolimus, infection, abscess, rectal abscess, surgery, drainage,
#2130 Remote Tracking of Symptoms, QoL and Wellbeing within the New Wales NET Service
Introduction: Patients with NETs have worse health-related quality of life (HRQoL) than the general population. Technological advances have significantly increased electronic patient-reported outcome (ePRO) data collection capabilities. There is little longitudinal PRO/ePRO data and limited data on gastrointestinal symptoms, particularly ‘diarrhoea’, in NET patients.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Reynolds M
Authors: Reynolds M, Tucker L, Ankita B, Powell C, Hopps R,
Keywords: Quality of Life, Symptoms, ePRO, Diarrhoea, NET service, Longitudinal Data, CABARET, app,
Introduction: The majority of patients diagnosed with gastroenteropancreatic (GEP)-NETs present metastases expressing somatostatin receptor 2 (SSTR2). The 68Gallium-labelled SSTR2 antagonist 68Ga-OPS202 has shown improved diagnostic performance as a PET imaging agent compared with the SSTR2 agonist 68Ga-DOTA-TOC in a single-centre study.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Virgolini I, Brouwers A, Haug A, Grønbæk H, Kjær A,
Keywords: 68Ga-OPS202, GEP-NET, SSTR2, optimal dose range,